July 22, 2014 7:52 PM ET


Company Overview of Erimos Pharmaceuticals, LLC

Company Overview

Erimos Pharmaceuticals, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics to treat cancer and viral diseases. Its Terameprocol is an intravenous therapy for the treatment of refractory and metastatic solid tumors. Erimos Pharmaceuticals, LLC was formerly known as BioCure Technologies, LLC and changed its name to Erimos Pharmaceuticals, LLC in January 2004. The company was founded in 2000 and is based in Houston, Texas with an additional office in Houston, Texas. It has research and development facilities in Raleigh, North Carolina; and manufacturing facilities in Mexico.

9600 Bellaire Boulevard

Suite 228

Houston, TX 77036

United States

Founded in 2000





Key Executives for Erimos Pharmaceuticals, LLC

Chief Executive Officer
Co-Founder and Executive Chairman
Chief Operating Officer and Chief Medical Officer
Age: 58
Chief Business Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Amneal Pharmaceuticals, L.L.C. United States
Help Remedies, Inc. United States
Sun Hope International Corporation United States
Pro Pac Labs, Inc. United States
pSivida US, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Erimos Pharmaceuticals, LLC, please visit www.erimos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.